[1]. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study.
Emerging microbes & infections [巻]12 [号]1 [頁]2155250 （2023年） [査読] 有
[DOI] [2]. Falsely elevated thyroid hormone levels associated with fibrin interference in patients receiving oral anticoagulant therapy.
Annals of clinical biochemistry [頁]45632231159280 （2023年） [査読] 有
[DOI] [3]. Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.
Respiratory investigation [巻]61 [号]2 [頁]210 -219 （2023年） [査読] 有
[DOI] [4]. Falsely elevated thyroid hormone levels associated with fibrin interference in patients receiving oral anticoagulant therapy.
Ann Clin Biochem SAGE journals [頁]45632231159280 （2023年） [査読] 有
[DOI] [5]. Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialists
RESPIROLOGY （2023年） [査読] 有
[DOI] [機関リポジトリ][6]. Enhanced immune complex formation in the lungs of patients with dermatomyositis
RESPIRATORY RESEARCH [巻]24 [号]1 （2023年） [査読] 有
[DOI] [7]. Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation
JOURNAL OF CLINICAL MEDICINE [巻]12 [号]6 （2023年） [査読] 有
[DOI] [8]. 治療法の再整理とアップデートのために 専門家による私の治療 膠原病肺
日本医事新報 (株)日本医事新報社 [号]5159 [頁]38 -39 （2023年） [査読] 無
[9]. A predictive model for acute exacerbation of idiopathic interstitial pneumonias.
The European respiratory journal （2023年） [査読] 有
[DOI] [機関リポジトリ][10]. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
EXPERT REVIEW OF RESPIRATORY MEDICINE （2023年） [査読] 有
[DOI] [11]. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY [巻]68 [号]2 [頁]201 -212 （2023年） [査読] 有
[DOI] [12]. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry.
Respiratory investigation [巻]61 [号]1 [頁]95 -102 （2023年） [査読] 有
[DOI] [13]. Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trial
RESPIROLOGY （2023年） [査読] 有
[DOI] [14]. Association between increased peripheral blood CD86-positive plasmacytoid dendritic cells and immune-related adverse events in patients with non-small cell lung cancer.
Global health & medicine [巻]4 [号]6 [頁]301 -308 （2022年） [査読] 有
[DOI] [15]. Idiopathic pleuroparenchymal fibroelastosis: three-dimensional computed tomography assessment of upper-lobe lung volume
EUROPEAN RESPIRATORY JOURNAL [巻]60 [号]6 （2022年） [査読] 有
[DOI] [16]. Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study
THORAX （2022年） [査読] 有
[DOI] [17]. Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway
CELLULAR SIGNALLING [巻]99 （2022年） [査読] 有
[DOI] [18]. Chromatin-remodeling factor BAZ1A/ACF1 targets UV damage sites in an MLL1-dependent manner to facilitate nucleotide excision repair
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH [巻]1869 [号]11 （2022年） [査読] 有
[DOI] [19]. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
Respiratory investigation [巻]60 [号]6 [頁]779 -786 （2022年） [査読] 有
[DOI] [20]. Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
Respiratory investigation [巻]60 [号]6 [頁]787 -797 （2022年） [査読] 有
[DOI] [21]. Current treatment status of patients with idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
Respiratory investigation [巻]60 [号]6 [頁]806 -814 （2022年） [査読] 有
[DOI] [22]. Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
Respiratory investigation [巻]60 [号]6 [頁]798 -805 （2022年） [査読] 有
[DOI] [23]. 【呼吸器難病の課題と展望】サルコイドーシス
呼吸器内科 (有)科学評論社 [巻]42 [号]5 [頁]463 -467 （2022年） [査読] 無
[24]. 【間質性肺疾患の研究と診療UPDATE】間質性肺疾患における緩和医療
医学のあゆみ 医歯薬出版(株) [巻]283 [号]1 [頁]88 -94 （2022年） [査読] 無
[25]. End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
RESPIRATORY RESEARCH [巻]23 [号]1 （2022年） [査読] 有
[DOI] [26]. Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
BMC PULMONARY MEDICINE [巻]22 [号]1 （2022年） [査読] 有
[DOI] [27]. A Case of Hepatic Angiosarcoma with Peliosis Hepatis.
Internal medicine (Tokyo, Japan) （2022年） [査読] 有
[DOI] [28]. 【びまん性肺疾患-病態・臨床の最新知見-】特論 間質性肺疾患の緩和医療 現状と課題
日本臨床 (株)日本臨床社 [巻]80 [号]9 [頁]1509 -1516 （2022年） [査読] 無
[機関リポジトリ][29]. Nationwide retrospective observational study of idiopathic dendriform pulmonary ossification: clinical features with a progressive phenotype
BMJ OPEN RESPIRATORY RESEARCH [巻]9 [号]1 （2022年） [査読] 有
[DOI] [30]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma
AUTOPHAGY [巻]18 [号]9 [頁]2216 -2228 （2022年） [査読] 有
[DOI] [31]. Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.
Respiratory medicine case reports [巻]37 [頁]101632 （2022年） [査読] 有
[DOI] [32]. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
International journal of molecular sciences [巻]23 [号]16 （2022年） [査読] 有
[DOI] [33]. Multiple organ infarction caused by aortic thrombus in a lung cancer patient with the mutation.
Respiratory medicine case reports [巻]36 [頁]101608 （2022年） [査読] 有
[DOI] [34]. Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies.
Respiratory medicine case reports [巻]36 [頁]101606 （2022年） [査読] 有
[DOI] [35]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis
THORAX [巻]77 [号]7 [頁]727 -730 （2022年） [査読] 有
[DOI] [36]. Associations of serum long-chain fatty acids with multiple organ involvement in patients with sarcoidosis
BMC PULMONARY MEDICINE [巻]22 [号]1 （2022年） [査読] 有
[DOI] [37]. Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY （2022年） [査読] 有
[DOI] [38]. Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
JOURNAL OF RHEUMATOLOGY [巻]49 [号]7 [頁]707 -718 （2022年） [査読] 有
[DOI] [39]. 中井ら"気管支鏡で診断した特発性びまん性肺骨化症の1例"
気管支学 (NPO)日本呼吸器内視鏡学会 [巻]44 [号]4 [頁]255 -256 （2022年） [査読] 有
[DOI] [40]. 【間質性肺疾患:実地臨床における診療のポイント】膠原病に伴う間質性肺疾患
日本内科学会雑誌 (一社)日本内科学会 [巻]111 [号]6 [頁]1092 -1098 （2022年） [査読] 無
[41]. Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia
SCIENTIFIC REPORTS [巻]12 [号]1 （2022年） [査読] 有
[DOI] [42]. Chemotherapy for patients with advanced lung cancer with interstitial, lung disease: a prospective observational study
THERAPEUTIC ADVANCES IN CHRONIC DISEASE [巻]13 （2022年） [査読] 有
[DOI] [43]. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis
RESPIRATORY RESEARCH [巻]23 [号]1 （2022年） [査読] 有
[DOI] [44]. 【ACPの向かう道 11人の実践者による誌上シンポジウム】非がん性呼吸器疾患にACPを広げるうえでの課題
緩和ケア (株)青海社 [巻]32 [号]3 [頁]209 -213 （2022年） [査読] 無
[45]. Effects of long-acting muscarinic antagonists on promoting ciliary function in airway epithelium
BMC PULMONARY MEDICINE [巻]22 [号]1 （2022年） [査読] 有
[DOI] [46]. 【マイナーエマージェンシー 外来診療・一人当直に強くなる!いざというときの対処法】内科的minor emergency 気胸
Medical Practice (株)文光堂 [巻]39 [号]臨増 [頁]88 -90 （2022年） [査読] 無
[47]. PF-ILD の臨床像：呼吸器内科の視点から
炎症と免疫 （2022年） [査読] 無
[48]. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study
RESPIRATORY RESEARCH [巻]23 [号]1 （2022年） [査読] 有
[DOI] [49]. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Thorax （2022年） [査読] 有
[DOI] [機関リポジトリ][50]. Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.
BMC cancer [巻]22 [号]1 [頁]310 （2022年） [査読] 有
[DOI] [51]. mA demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer.
Cancer gene therapy （2022年） [査読] 有
[DOI] [52]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Respiratory research [巻]23 [号]1 [頁]57 （2022年） [査読] 有
[DOI] [53]. Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
BMC CANCER [巻]22 [号]1 （2022年）
[DOI] [54]. m(6)A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer
CANCER GENE THERAPY （2022年）
[DOI] [55]. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
RESPIRATORY RESEARCH [巻]23 [号]1 （2022年）
[DOI] [56]. 抗MDA5抗体、抗ARS抗体、抗TIF1γ抗体、抗Mi-2抗体陽性多発性筋炎/皮膚筋炎患者の臨床的特徴
日本皮膚科学会雑誌 (公社)日本皮膚科学会 [巻]132 [号]3 [頁]514 （2022年）
[57]. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
Respiratory research [巻]23 [号]1 [頁]24 （2022年） [査読] 有
[DOI] [58]. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Thorax [巻]77 [号]2 [頁]143 -153 （2022年） [査読] 有
[DOI] [59]. 本邦のナショナルデータベースを用いたCOVID-19の大規模疫学調査
日本内科学会雑誌 (一社)日本内科学会 [巻]111 [号]Suppl. [頁]219 （2022年）
[60]. 【びまん性肺疾患における多職種合議(MDD)診断とAI支援の現在と未来】特発性間質性肺炎(IIPs)におけるMDDの重要性について
呼吸器内科 (有)科学評論社 [巻]41 [号]2 [頁]138 -141 （2022年）
[61]. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
RESPIRATORY RESEARCH [巻]23 [号]1 （2022年）
[DOI] [62]. 【びまん性肺疾患における多職種合議(MDD)診断とAI支援の現在と未来】特発性間質性肺炎(IIPs)におけるMDDの重要性について
呼吸器内科 (有)科学評論社 [巻]41 [号]2 [頁]138 -141 （2022年） [査読] 無
[63]. Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias
THORAX [巻]77 [号]2 [頁]143 -153 （2022年） [査読] 有
[DOI] [64]. Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis.
Internal medicine (Tokyo, Japan) [巻]61 [号]3 [頁]395 -400 （2022年） [査読] 有
[DOI] [65]. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma.
Autophagy [頁]1 -13 （2022年） [査読] 有
[DOI] [66]. Sarcoid-like Granulomatous Lung Disease with Subacute Progression in Silicosis
INTERNAL MEDICINE [巻]61 [号]3 [頁]395 -400 （2022年）
[DOI] [67]. Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Therapeutic advances in chronic disease [巻]13 [頁]20406223221108395 （2022年）
[DOI] [68]. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY [巻]78 [号]1 [頁]77 -87 （2022年）
[DOI] [69]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer
CANCER IMMUNOLOGY IMMUNOTHERAPY [巻]71 [号]1 [頁]203 -217 （2022年）
[DOI] [70]. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients.
European journal of clinical pharmacology [巻]78 [号]1 [頁]77 -87 （2022年） [査読] 有
[71]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy
JOURNAL OF IMMUNOTHERAPY [巻]45 [号]2 [頁]125 -131 （2022年）
[DOI] [72]. Array
JTO clinical and research reports [巻]3 [号]1 [頁]100264 （2022年） [査読] 有
[DOI] [73]. Marked, Lasting Disease Regression and Concomitantly Induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in a Patient With Lung Adenocarcinoma and Autoantibodies Receiving Atezolizumab Plus Chemotherapy: A Case Report.
JTO clinical and research reports [巻]3 [号]1 [頁]100263 （2022年） [査読] 有
[DOI] [74]. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients.
European journal of clinical pharmacology [巻]78 [号]1 [頁]77 -87 （2022年） [査読] 有
[DOI] [75]. Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
Cancer immunology, immunotherapy : CII [巻]71 [号]1 [頁]203 -217 （2022年） [査読] 有
[DOI] [76]. Transient leukocytopenia following combination therapy for COVID-19.
Respiratory investigation [巻]60 [号]1 [頁]158 -161 （2022年） [査読] 有
[DOI] [77]. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
BMC pulmonary medicine [巻]21 [号]1 [頁]409 （2021年） [査読] 有
[DOI] [78]. 【膠原病に合併する進行性線維化を伴う間質性肺疾患】PF-ILDの臨床像 呼吸器内科の視点から
炎症と免疫 (株)先端医学社 [巻]30 [号]1 [頁]67 -71 （2021年） [査読] 無
[79]. Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis.
Chest [巻]160 [号]6 [頁]2149 -2157 （2021年） [査読] 有
[DOI] [機関リポジトリ][80]. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).
BMJ open respiratory research [巻]8 [号]1 （2021年） [査読] 有
[DOI] [81]. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Respiratory research [巻]22 [号]1 [頁]290 （2021年） [査読] 有
[DOI] [82]. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Respiratory investigation [巻]59 [号]6 [頁]709 -740 （2021年） [査読] 有
[DOI] [83]. Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis.
Respiratory investigation [巻]59 [号]6 [頁]827 -836 （2021年） [査読] 有
[DOI] [機関リポジトリ][84]. Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
BMC pulmonary medicine [巻]21 [号]1 [頁]309 （2021年） [査読] 有
[DOI] [85]. 【呼吸器症候群(第3版)-その他の呼吸器疾患を含めて-】各種疾患にみられる呼吸器病変 自己免疫疾患 強直性脊椎炎
日本臨床 (株)日本臨床社 [巻]別冊 [号]呼吸器症候群III [頁]277 -281 （2021年） [査読] 無
[86]. 【呼吸器症候群(第3版)-その他の呼吸器疾患を含めて-】びまん性肺疾患 間質性肺炎 膠原病肺
日本臨床 (株)日本臨床社 [巻]別冊 [号]呼吸器症候群III [頁]40 -46 （2021年） [査読] 無
[87]. 【間質性肺疾患と肺線維症】間質性肺疾患における肺線維化のメカニズム PF-ILDを中心に
BIO Clinica (株)北隆館 [巻]36 [号]11 [頁]1051 -1055 （2021年） [査読] 無
[88]. Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide.
Cancer treatment and research communications [巻]29 [頁]100493 （2021年） [査読] 有
[DOI] [89]. Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial.
Respiratory medicine [巻]187 [頁]106574 （2021年） [査読] 有
[DOI] [90]. Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts.
American journal of translational research [巻]13 [号]11 [頁]12318 -12337 （2021年） [査読] 有
[91]. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
Scientific reports [巻]11 [号]1 [頁]18579 （2021年） [査読] 有
[DOI] [92]. Impairment of the Hypothalamus-Pituitary-Thyroid Axis Caused by Naturally Occurring Mutations In Vitro.
International journal of molecular sciences [巻]22 [号]18 （2021年） [査読] 有
[DOI] [93]. Impairment of the Hypothalamus-Pituitary-Thyroid Axis Caused by Naturally Occurring GATA2 Mutations In Vitro
International Journal of Molecular Sciences Multidisciplinary Digital Publishing Institute (MDPI) [巻]22 [号]18 [頁]1 -13 （2021年） [査読] 有
[DOI] [94]. 【好酸球性肺疾患Update】急性好酸球性肺炎と慢性好酸球性肺炎
呼吸器内科 (有)科学評論社 [巻]40 [号]3 [頁]223 -228 （2021年） [査読] 無
[機関リポジトリ][95]. Multicentric Castleman disease with infiltration of eosinophils to the lung.
Respiratory medicine case reports [巻]34 [頁]101458 （2021年） [査読] 有
[DOI] [96]. COVID-19 and acute exacerbation of interstitial lung disease.
Respiratory investigation [巻]59 [号]5 [頁]675 -678 （2021年） [査読] 有
[DOI] [97]. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Respiratory medicine [巻]186 [頁]106534 （2021年） [査読] 有
[DOI] [98]. YTHDF1 and YTHDF2 are associated with better patient survival and an inflamed tumor-immune microenvironment in non-small-cell lung cancer.
Oncoimmunology [巻]10 [号]1 [頁]1962656 （2021年） [査読] 有
[DOI] [99]. 【間質性肺炎 徹底討論!-鳥からは逃げられない過敏性肺炎,放置してよいのかILA】間質性肺炎の診断と治療においてわかってきたこと,これからしなければいけないこと
呼吸器ジャーナル (株)医学書院 [巻]69 [号]3 [頁]308 -317 （2021年） [査読] 無
[DOI] [100]. Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertension.
Scientific reports [巻]11 [号]1 [頁]15502 （2021年） [査読] 有
[DOI] [101]. Comparative assessment of NOIR-SS and ddPCR for ctDNA detection of EGFR L858R mutations in advanced L858R-positive lung adenocarcinomas.
Scientific reports [巻]11 [号]1 [頁]14999 （2021年） [査読] 有
[DOI] [102]. Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.
BMC cancer [巻]21 [号]1 [頁]832 （2021年） [査読] 有
[DOI] [103]. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
BMC pulmonary medicine [巻]21 [号]1 [頁]221 （2021年） [査読] 有
[DOI] [104]. Importance of Imaging Procedures in the Evaluation of Methotrexate-Associated Lymphoproliferative Disorder of the Thyroid Gland: A Case Study.
European thyroid journal [巻]10 [号]5 [頁]434 -436 （2021年） [査読] 有
[DOI] [105]. Clinical characteristics of four myositis-specific autoantibodies with regulatory-approved testing in Japan: A Japanese multi-centre adult myositis patients' cohort.
Journal of dermatological science [巻]103 [号]1 [頁]53 -56 （2021年） [査読] 有
[DOI] [106]. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates.
European thyroid journal [巻]10 [号]5 [頁]372 -381 （2021年） [査読] 有
[DOI] [107]. 診断に苦慮した全身性肥満細胞症の1例
日本内科学会雑誌 (一社)日本内科学会 [巻]110 [号]7 [頁]1467 -1472 （2021年） [査読] 有
[108]. Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.
Allergology international : official journal of the Japanese Society of Allergology [巻]70 [号]3 [頁]351 -359 （2021年） [査読] 有
[DOI] [109]. Systemic Air Embolism and Mediastinal Emphysema after Pneumonia.
American journal of respiratory and critical care medicine [巻]204 [号]1 [頁]95 -96 （2021年） [査読] 有
[DOI] [110]. CD8-positive peripheral T cell lymphoma in a patient following long-term nivolumab for advanced lung adenocarcinoma: A case report.
Thoracic cancer [巻]12 [号]11 [頁]1765 -1769 （2021年） [査読] 有
[DOI] [111]. Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis.
European journal of immunology [巻]51 [号]6 [頁]1519 -1530 （2021年） [査読] 有
[DOI] [112]. Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.
Lung [巻]199 [号]3 [頁]289 -298 （2021年） [査読] 有
[DOI] [113]. Hyperfunctioning Papillary Thyroid Carcinoma with a Mutation: The First Case Report and a Literature Review.
European thyroid journal [巻]10 [号]3 [頁]262 -267 （2021年） [査読] 有
[DOI] [114]. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
Respiratory medicine [巻]182 [頁]106420 （2021年） [査読] 有
[DOI] [115]. 日本呼吸器学会会員における大学院進学に関する最近の動向
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]10 [号]3 [頁]207 -211 （2021年） [査読] 有
[116]. Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.
Scientific reports [巻]11 [号]1 [頁]9120 （2021年） [査読] 有
[DOI] [117]. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Respiratory research [巻]22 [号]1 [頁]115 （2021年） [査読] 有
[DOI] [118]. Simple method for detecting idiopathic interstitial pneumonias by measuring vertical lung length on chest X-ray.
Scientific reports [巻]11 [号]1 [頁]7669 （2021年） [査読] 有
[DOI] [119]. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Journal of clinical medicine [巻]10 [号]7 （2021年） [査読] 有
[DOI] [120]. Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Respirology (Carlton, Vic.) [巻]26 [号]4 [頁]370 -377 （2021年） [査読] 有
[DOI] [121]. 抗甲状腺薬はバセドウ病合併妊娠後期の母児間FT4値を用量依存的に乖離させる
日本内分泌学会雑誌 (一社)日本内分泌学会 [巻]97 [号]1 [頁]267 （2021年） [査読] 有
[122]. 肺野末梢の腺様嚢胞癌の1例
肺癌 (NPO)日本肺癌学会 [巻]61 [号]2 [頁]155 （2021年） [査読] 有
[123]. Exposure to PM is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study.
Respiratory research [巻]22 [号]1 [頁]80 （2021年）
[DOI] [124]. Hyperfunctioning Papillary Thyroid Carcinoma with a BRAF Mutation: The First Case Report and a Literature Review
European Thyroid Journal Karger （2021年） [査読] 有
[URL] [DOI] [125]. Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study.
Open forum infectious diseases [巻]8 [号]3 [頁]ofab068 （2021年） [査読] 有
[DOI] [126]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study
THORAX [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [127]. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis
CLINICAL RESPIRATORY JOURNAL [巻]15 [号]3 [頁]336 -344 （2021年） [査読] 有
[DOI] [128]. Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study
RESPIRATORY RESEARCH [巻]22 [号]1 （2021年） [査読] 有
[DOI] [129]. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study.
Thorax [巻]76 [号]3 [頁]248 -255 （2021年） [査読] 有
[DOI] [130]. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
The clinical respiratory journal [巻]15 [号]3 [頁]336 -344 （2021年）
[DOI] [131]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
BMC pulmonary medicine [巻]21 [号]1 [頁]63 （2021年）
[DOI] [132]. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
Nature communications [巻]12 [号]1 [頁]1032 （2021年）
[DOI] [133]. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Chest [巻]159 [号]6 [頁]2334 -2345 （2021年） [査読] 有
[DOI] [機関リポジトリ][134]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [巻]27 [号]2 [頁]373 -378 （2021年）
[DOI] [135]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
Respirology (Carlton, Vic.) [巻]26 [号]2 [頁]171 -179 （2021年）
[DOI] [136]. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Investigational new drugs [巻]39 [号]1 [頁]210 -216 （2021年）
[DOI] [137]. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
NATURE COMMUNICATIONS [巻]12 [号]1 （2021年） [査読] 有
[DOI] [138]. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receivingantifibrotictherapy
RESPIROLOGY [巻]26 [号]2 [頁]171 -179 （2021年） [査読] 有
[DOI] [機関リポジトリ][139]. Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival
BMC PULMONARY MEDICINE [巻]21 [号]1 （2021年） [査読] 有
[DOI] [140]. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-gamma autoantibody associated disseminated nontuberculous mycobacterial infection
JOURNAL OF INFECTION AND CHEMOTHERAPY [巻]27 [号]2 [頁]373 -378 （2021年） [査読] 有
[DOI] [機関リポジトリ][141]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors
RESPIRATION [巻]100 [号]1 [頁]19 -26 （2021年） [査読] 有
[DOI] [142]. Erlotinib and bevacizumab in elderly patients >= 75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations
INVESTIGATIONAL NEW DRUGS [巻]39 [号]1 [頁]210 -216 （2021年） [査読] 有
[DOI] [機関リポジトリ][143]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease.
Scientific reports [巻]11 [号]1 [頁]1682 （2021年）
[DOI] [144]. IPAFとPF-ILD
呼吸器内科 [頁]207 -211 （2021年） [査読] 無
[機関リポジトリ][145]. EGFR遺伝子変異陽性肺腺癌と陰性肺腺癌が併存し同時性多発肺癌と考えられた1例
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]10 [号]1 [頁]50 -54 （2021年）
[146]. The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis.
Hepatology research : the official journal of the Japan Society of Hepatology [巻]51 [号]1 [頁]80 -89 （2021年）
[DOI] [147]. Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.
The European respiratory journal [巻]57 [号]1 （2021年）
[DOI] [148]. Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial
EUROPEAN RESPIRATORY JOURNAL [巻]57 [号]1 （2021年） [査読] 有
[DOI] [149]. The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
HEPATOLOGY RESEARCH [巻]51 [号]1 [頁]80 -89 （2021年） [査読] 有
[DOI] [150]. Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
SCIENTIFIC REPORTS [巻]11 [号]1 （2021年） [査読] 有
[DOI] [151]. EGFR遺伝子変異陽性肺腺癌と陰性肺腺癌が併存し同時性多発肺癌と考えられた1例
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]10 [号]1 [頁]50 -54 （2021年） [査読] 有
[152]. Benralizumab as initial treatment for chronic eosinophilic pneumonia.
Allergology international : official journal of the Japanese Society of Allergology [巻]70 [号]1 [頁]140 -142 （2021年） [査読] 有
[DOI] [153]. 診療ガイドラインat a glance 炎症性疾患に対する生物学的製剤と呼吸器疾患診療の手引き(第2版)
日本内科学会雑誌 (一社)日本内科学会 [巻]109 [号]12 [頁]2531 -2538 （2020年） [査読] 無
[154]. IPAFの枠組みを考える
呼吸器内科 (有)科学評論社 [巻]38 [号]6 [頁]582 -587 （2020年） [査読] 無
[機関リポジトリ][155]. CD206(マクロファージマンノース受容体)による抗MDA5抗体陽性皮膚筋炎に合併する間質性肺炎の重症度分類
リウマチ科 (有)科学評論社 [巻]64 [号]6 [頁]713 -719 （2020年） [査読] 無
[機関リポジトリ][156]. 【リウマチ性疾患治療薬の最新の知見】全身性強皮症に伴う肺線維症に対する抗線維化薬ニンテダニブ
リウマチ科 (有)科学評論社 [巻]64 [号]6 [頁]677 -684 （2020年） [査読] 無
[機関リポジトリ][157]. GATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor β2 in the rat hypothalamic paraventricular nucleus.
PLoS One Public Library of Science [巻]15 [号]11 [頁]e0242380 （2020年） [査読] 有
[DOI] [158]. G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor beta 2 in the rat hypothalamic paraventricular nucleus
PLOS ONE [巻]15 [号]11 （2020年） [査読] 有
[DOI] [159]. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT [巻]60 [号]5 [頁]933 -940 （2020年） [査読] 有
[DOI] [機関リポジトリ][160]. Leucine-Rich alpha(2)-Glycoprotein as a Potential Biomarker for Immune-related Colitis After Anti-PD-L1 Therapy: A Report of a Case Series
CLINICAL LUNG CANCER [巻]21 [号]6 [頁]E516 -E522 （2020年） [査読] 有
[DOI] [機関リポジトリ][161]. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium
RESPIRATORY RESEARCH [巻]21 [号]1 （2020年） [査読] 有
[DOI] [162]. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium
MICROBIOLOGY AND IMMUNOLOGY [巻]64 [号]10 [頁]666 -678 （2020年） [査読] 有
[DOI] [163]. Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data
CANCER SCIENCE [巻]111 [号]10 [頁]3705 -3713 （2020年） [査読] 有
[DOI] [164]. 喘息のステップアップ治療における長時間作用性抗コリン薬とロイコトリエン受容科拮抗薬の有用性の比較
アレルギー (一社)日本アレルギー学会 [巻]69 [号]臨時増刊号 [頁]305 （2020年） [査読] 有
[165]. 関節リウマチに対するセルトリズマブペゴル投与中に発症したサルコイドーシスの1例
日本サルコイドーシス/肉芽腫性疾患学会雑誌 日本サルコイドーシス [巻]40 [号]1-2 [頁]63 -64 （2020年） [査読] 有
[166]. 石綿肺にNSIPパターンの間質性肺炎と二次性肺胞蛋白症を合併した1例
日本職業・環境アレルギー学会雑誌 日本職業・環境アレルギー学会 [巻]28 [号]1 [頁]62 （2020年） [査読] 有
[167]. 【アレルギー性肺疾患の新知見】好酸球性肺炎の新知見
臨床免疫・アレルギー科 (有)科学評論社 [巻]74 [号]4 [頁]333 -339 （2020年） [査読] 有
[機関リポジトリ][168]. 非結核性抗酸菌症治療のカッティングエッジ 肺MAC症治療におけるリファンピシンの意義について
結核 (一社)日本結核・非結核性抗酸菌症学会 [巻]95 [号]5 [頁]63 （2020年） [査読] 有
[169]. わが国の呼吸器臨床病理の現状と問題点 病理医のアンケート結果より
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]9 [号]5 [頁]311 -318 （2020年） [査読] 有
[170]. Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer
JAMA NETWORK OPEN [巻]3 [号]9 （2020年） [査読] 有
[DOI] [171]. HDAC3 Is Required for XPC Recruitment and Nucleotide Excision Repair of DNA Damage Induced by UV Irradiation
MOLECULAR CANCER RESEARCH [巻]18 [号]9 [頁]1367 -1378 （2020年） [査読] 有
[DOI] [172]. Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE [巻]14 （2020年） [査読] 有
[DOI] [173]. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis
RESPIRATORY MEDICINE [巻]171 （2020年） [査読] 有
[DOI] [機関リポジトリ][174]. Genetic control of CCL24, POR, and IL23R contributes to the pathogenesis of sarcoidosis
COMMUNICATIONS BIOLOGY [巻]3 [号]1 （2020年） [査読] 有
[DOI] [175]. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study
JOURNAL OF THORACIC ONCOLOGY [巻]15 [号]8 [頁]1317 -1327 （2020年） [査読] 有
[DOI] [機関リポジトリ][176]. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy
RESPIRATORY MEDICINE [巻]169 （2020年） [査読] 有
[DOI] [177]. 肺癌カルボプラチンレジメンにおけるオランザピン併用制吐療法の第II相試験
Palliative Care Research (NPO)日本緩和医療学会 [巻]15 [号]Suppl. [頁]S230 （2020年） [査読] 有
[178]. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature
INTERNAL MEDICINE [巻]59 [号]16 [頁]2015 -2021 （2020年） [査読] 有
[DOI] [179]. 治療法の再整理とアップデートのために 専門家による私の治療 じん肺症(珪肺、アスベスト肺)
日本医事新報 (株)日本医事新報社 [号]5024 [頁]38 -39 （2020年） [査読] 有
[180]. 重度の気流閉塞を有する喘息症例に対する気管支サーモプラスティ
アレルギーの臨床 (株)北隆館 [巻]40 [号]7 [頁]560 -563 （2020年） [査読] 有
[181]. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis
RESPIROLOGY [巻]25 [号]7 [頁]743 -749 （2020年） [査読] 有
[DOI] [機関リポジトリ][182]. Mediastinal Emphysema with Electrocardiogram Abnormality
INTERNAL MEDICINE [巻]59 [号]14 [頁]1783 -1784 （2020年） [査読] 有
[DOI] [183]. 経気管支鏡的に診断・切除し得た気管支内軟骨性過誤腫の1例
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]9 [号]4 [頁]262 -265 （2020年） [査読] 有
[184]. Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice
ANALYTICAL AND BIOANALYTICAL CHEMISTRY [巻]412 [号]18 [頁]4327 -4341 （2020年） [査読] 有
[DOI] [185]. Pneumothorax in connective tissue disease-associated interstitial lung disease
PLOS ONE [巻]15 [号]7 （2020年） [査読] 有
[DOI] [186]. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE [巻]14 （2020年） [査読] 有
[DOI] [187]. High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis
JAPANESE JOURNAL OF RADIOLOGY [巻]38 [号]6 [頁]524 -532 （2020年） [査読] 有
[DOI] [188]. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer
LUNG CANCER [巻]143 [頁]47 -54 （2020年） [査読] 有
[DOI] [189]. 心嚢水、胸水貯留を契機に診断し得た関節リウマチ合併amyloid light-chainアミロイドーシスの1例
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]9 [号]3 [頁]217 -221 （2020年） [査読] 有
[190]. Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants.
Endocrine Journal 日本内分泌学会 [巻]67 [号]4 [頁]449 -454 （2020年） [査読] 有
[DOI] [191]. 特発性間質性肺炎におけるクラウド型臨床・画像・病理統合データベースを用いた遠隔MDD の有用性
分子呼吸器病 [巻]24 [号]1 [頁]66 -69 （2020年） [査読] 無
[192]. Clinical Outcomes of Anti-programmed Death-1 Antibody-Related Pneumonitis in Patients with Non-small Cell Lung Cancer.
Clin. Med [頁]570 -578 （2020年） [査読] 有
[193]. CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant
PLOS ONE [巻]15 [号]4 （2020年） [査読] 有
[DOI] [194]. CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer
ONCOIMMUNOLOGY [巻]9 [号]1 （2020年） [査読] 有
[DOI] [195]. Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy
INTERNAL MEDICINE [巻]59 [号]7 [頁]987 -990 （2020年） [査読] 有
[DOI] [196]. Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants
ENDOCRINE JOURNAL [巻]67 [号]4 [頁]449 -454 （2020年） [査読] 有
[DOI] [197]. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Respiratory investigation （2020年） [査読] 有
[DOI] [198]. Endobronchial mucosal nodular lesions in allergic bronchopulmonary aspergillosis.
Respiratory medicine case reports [巻]29 [頁]100975 （2020年） [査読] 有
[DOI] [199]. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan.
Respiratory investigation [巻]58 [号]2 [頁]91 -101 （2020年） [査読] 有
[DOI] [200]. Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) [巻]141 [頁]21 -31 （2020年） [査読] 有
[DOI] [201]. Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer
LUNG CANCER [巻]141 [頁]21 -31 （2020年） [査読] 有
[DOI] [202]. Endobronchial Small-cell Lung Cancer with Intraluminal Growth Pattern Showing "Finger-in-glove" Appearance
INTERNAL MEDICINE [巻]59 [号]5 [頁]701 -704 （2020年） [査読] 有
[DOI] [203]. 残胃癌に対し残胃全摘術、膵頭十二指腸切除術を施行し長期生存を得られた1例
日本胃癌学会総会記事 (一社)日本胃癌学会 [巻]92回 [頁]445 （2020年）
[204]. 最先端研究紹介(第3回) 特発性間質性肺炎におけるクラウド型臨床・画像・病理統合データベースを用いた遠隔MDDの有用性
分子呼吸器病 (株)先端医学社 [巻]24 [号]1 [頁]66 -69 （2020年）
[205]. 化学療法後の局所遺残食道癌に対して放射線治療が奏効した1例
癌と化学療法 (株)癌と化学療法社 [巻]47 [号]3 [頁]510 -512 （2020年）
[206]. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Chronic respiratory disease [巻]16 [頁]1479972318809476 （2020年） [査読] 有
[DOI] [207]. Endobronchial Small-cell Lung Cancer with Intraluminal Growth Pattern Showing "Finger-in-glove" Appearance.
Internal medicine (Tokyo, Japan) [巻]59 [号]5 [頁]701 -704 （2020年） [査読] 有
[DOI] [208]. High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis.
Japanese journal of radiology （2020年） [査読] 有
[DOI] [209]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia (vol 9, 18750, 2019)
SCIENTIFIC REPORTS [巻]10 [号]1 （2020年）
[DOI] [210]. Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE [巻]14 （2020年）
[DOI] [211]. 胃癌術後腹膜転移による腸管狭窄に対しステントを留置しRamucirumabを投与できた1例
癌と化学療法 (株)癌と化学療法社 [巻]47 [号]2 [頁]313 -315 （2020年）
[212]. S状結腸垂のバンドにより絞扼性イレウスを発症した一例
日本腹部救急医学会雑誌 (一社)日本腹部救急医学会 [巻]40 [号]2 [頁]349 （2020年）
[213]. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes.
BMC pulmonary medicine [巻]20 [号]1 [頁]21 （2020年） [査読] 有
[DOI] [214]. Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants.
Endocrine journal （2020年） [査読] 有
[DOI] [215]. Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial.
American journal of respiratory and critical care medicine （2020年） [査読] 有
[DOI] [216]. Pulse oximetric saturation to fraction of inspired oxygen (SpO/FIO) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Therapeutic advances in respiratory disease [巻]14 [頁]1753466620906327 （2020年） [査読] 有
[DOI] [217]. CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes
BMC PULMONARY MEDICINE [巻]20 [号]1 （2020年）
[DOI] [218]. Liganded T3 receptor beta 2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production
PLOS ONE [巻]15 [号]1 （2020年）
[DOI] [219]. Liganded T3 receptor β2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production.
PloS one Public Library of Science [巻]15 [号]1 [頁]e0227646 （2020年） [査読] 有
[DOI] [220]. Quantitative LC-MS/MS method for nivolumab in human serum using IgG purification and immobilized tryptic digestion
ANALYTICAL METHODS [巻]12 [号]1 [頁]54 -62 （2020年）
[DOI] [221]. Clinical, radiological, and pathological evaluation of " NSIP with OP overlap " pattern compared with NSIP in patients with idiopathic interstitial pneumonias
RESPIRATORY MEDICINE [巻]174 （2020年）
[DOI] [222]. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia.
Scientific reports [巻]9 [号]1 [頁]18750 （2019年） [査読] 有
[DOI] [223]. 関節リウマチに伴った間質性肺炎に合併した悪性末梢神経鞘腫の1剖検例
肺癌 (NPO)日本肺癌学会 [巻]59 [号]7 [頁]1194 （2019年） [査読] 有
[224]. 先天性風疹症候群の高齢女性にみられた抗Jo-1抗体陽性間質性肺炎の1例
しょうけん: 浜松労災病院学術年報 (独)労働者健康安全機構浜松労災病院 [巻]2018 [頁]34 -36 （2019年） [査読] 無
[225]. 【全身性疾患と呼吸器疾患】IPAFは全身疾患であるか?
呼吸器内科 (有)科学評論社 [巻]36 [号]6 [頁]563 -567 （2019年） [査読] 無
[226]. 市中肺炎に対するレボフロキサシン・スイッチ療法の有効性・安全性の検討(Intravenous to Oral Levofloxacin Switch Therapy in Patients with Moderate Community-acquired Pneumonia: A Pilot Study)
新薬と臨牀 (株)医薬情報研究所 [巻]68 [号]12 [頁]1519 -1531 （2019年） [査読] 有
[227]. Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature - Reply.
Internal medicine (Tokyo, Japan) [巻]58 [号]23 [頁]3499 （2019年） [査読] 有
[DOI] [228]. Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.
Rheumatology (Oxford, England) [巻]58 [号]12 [頁]2143 -2152 （2019年） [査読] 有
[DOI] [229]. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3299 -3304 （2019年） [査読] 有
[DOI] [230]. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Internal medicine (Tokyo, Japan) [巻]58 [号]22 [頁]3267 -3271 （2019年） [査読] 有
[DOI] [231]. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Respiratory medicine [巻]159 [頁]105811 （2019年） [査読] 有
[DOI] [232]. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Respiratory investigation [巻]57 [号]6 [頁]552 -560 （2019年） [査読] 有
[DOI] [233]. 日本呼吸器学会の会員、専門医の最近の動向に関する検討
日本呼吸器学会誌 (一社)日本呼吸器学会 [巻]8 [号]6 [頁]375 -385 （2019年） [査読] 有
[234]. Minute Pulmonary Meningothelial-like Nodules Showing Multiple Ring-shaped Opacities.
Internal medicine (Tokyo, Japan) [巻]58 [号]21 [頁]3149 -3152 （2019年） [査読] 有
[DOI] [235]. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.
Allergology international : official journal of the Japanese Society of Allergology [巻]68 [号]4 [頁]413 -419 （2019年） [査読] 有
[DOI] [236]. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
The Journal of infection [巻]79 [号]4 [頁]341 -348 （2019年） [査読] 有
[DOI] [237]. 【びまん性肺疾患診療の新しい展開】膠原病関連びまん性肺疾患
臨牀と研究 大道学館出版部 [巻]96 [号]10 [頁]1189 -1197 （2019年） [査読] 無
[238]. Effect of rifampicin and clarithromycin on the CYP3A activity in patients with complex.
Journal of thoracic disease [巻]11 [号]9 [頁]3814 -3821 （2019年） [査読] 有
[DOI] [239]. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Respiratory medicine [巻]154 [頁]122 -126 （2019年） [査読] 有
[DOI] [240]. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
Respiratory medicine [巻]154 [頁]102 -108 （2019年） [査読] 有
[DOI] [241]. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.
Lung cancer (Amsterdam, Netherlands) [巻]134 [頁]202 -209 （2019年） [査読] 有
[DOI] [242]. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
The Journal of rheumatology [巻]46 [号]8 [頁]935 -942 （2019年） [査読] 有
[DOI] [243]. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Respirology (Carlton, Vic.) [巻]24 [号]8 [頁]792 -798 （2019年） [査読] 有
[DOI] [244]. 【特発性間質性肺炎:臨床診断の現状と課題】IPAFを考える
呼吸器内科 (有)科学評論社 [巻]36 [号]2 [頁]137 -142 （2019年） [査読] 無
[245]. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites.
Lung cancer (Amsterdam, Netherlands) ELSEVIER [巻]134 [頁]202 -209 （2019年） [査読] 有
[DOI] [246]. Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature.
Internal medicine (Tokyo, Japan) [巻]58 [号]15 [頁]2207 -2211 （2019年） [査読] 有
[DOI] [247]. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Scientific reports [巻]9 [号]1 [頁]10484 （2019年） [査読] 有
[DOI] [248]. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.
Cancer chemotherapy and pharmacology [巻]84 [号]1 [頁]147 -153 （2019年） [査読] 有
[DOI] [249]. 感染症病床における結核管理と地域医療連携のための指針
結核 (一社)日本結核病学会 [巻]94 [号]7 [頁]425 -429 （2019年） [査読] 有
[250]. 【今日の呼吸器診療と今後の展望】知っておきたい呼吸器疾患 生物学的製剤と呼吸器疾患
内科 (株)南江堂 [巻]124 [号]1 [頁]1471 -1474 （2019年） [査読] 無
[DOI] [251]. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
Respiratory investigation [巻]57 [号]4 [頁]312 -320 （2019年） [査読] 有
[DOI] [252]. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Investigational new drugs [巻]37 [号]3 [頁]531 -537 （2019年） [査読] 有
[DOI] [253]. Physiological and morphological differences of airways between COPD and asthma-COPD overlap.
Scientific reports [巻]9 [号]1 [頁]7818 （2019年） [査読] 有
[DOI] [254]. Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.
Scientific reports [巻]9 [号]1 [頁]7355 （2019年） [査読] 有
[DOI] [255]. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
The Journal of rheumatology [巻]46 [号]5 [頁]509 -517 （2019年） [査読] 有
[DOI] [256]. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.
The European respiratory journal [巻]53 [号]5 （2019年） [査読] 有
[DOI] [257]. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine [巻]199 [号]8 [頁]1031 -1033 （2019年） [査読] 有
[DOI] [258]. 局所麻酔下胸腔鏡にて確定診断した胸膜病変を伴った悪性リンパ腫の1例
肺癌 (NPO)日本肺癌学会 [巻]59 [号]2 [頁]188 -189 （2019年） [査読] 有
[259]. Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis.
Clinical case reports [巻]7 [号]4 [頁]731 -734 （2019年） [査読] 有
[DOI] [260]. Anti-Jo-1 Antibody-positive Interstitial Pneumonia in an Elderly Patient with Congenital Rubella Syndrome.
Internal medicine (Tokyo, Japan) [巻]58 [号]14 [頁]2063 -2066 （2019年） [査読] 有
[DOI] [261]. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1333 -1342 （2019年） [査読] 有
[DOI] [262]. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
Journal of asthma and allergy [巻]12 [頁]253 -261 （2019年） [査読] 有
[DOI] [263]. G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells.
PloS one [巻]14 [号]9 [頁]e0222179 （2019年） [査読] 有
[DOI] [264]. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
International journal of chronic obstructive pulmonary disease [巻]14 [頁]1867 -1877 （2019年） [査読] 有
[DOI] [265]. The Mechanism of Negative Transcriptional Regulation by Thyroid Hormone: Lessons From the Thyrotropin β Subunit Gene.
Vitamins and hormones エルゼビア [巻]106 [頁]97 -127 （2018年） [査読] 無
[DOI] [266]. Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Respiration; international review of thoracic diseases [巻]100 [号]1 [頁]19 -26
[DOI] [267]. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) [巻]45 [号]2 [頁]125 -131
[DOI]